Autism is the most common neurodevelopmental disorder in the U.S., affecting an estimated one out of 36 children.
FDA Denies Lykos and Requests Another Trial | Psychedelic Invest
The FDA issued a complete response letter regarding Lykos’ drug application for its midomafetamine capsules, an MDMA-based treatment designed for adults with PTSD. The agency,